查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1514974

基於 RNA 的治療和疫苗市場，按產品類型、應用、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

RNA-based Therapeutics and Vaccines Market, By Product Type, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 262 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023 年，基於 RNA 的治療和疫苗市場規模為 200 萬美元，2024 年至 2032 年複合年成長率為 65.10%。

基於 RNA 的治療與疫苗市場-市場動態

RNA 遞送技術和個人化藥物的進步預計將推動市場需求

基於 RNA 的療法，例如 mRNA 療法，有望實現個人化醫療。它們可以針對個別患者特有的特定基因突變或疾病機制進行客製化。這種客製化的潛力與精準醫學的發展趨勢相一致，即治療擴大根據個體遺傳特徵和疾病特徵進行客製化。因此，對個人化治療和藥物的需求增加預計將推動市場成長。此外，脂質奈米顆粒 (LNP) 和其他遞送系統的進步顯著提高了 RNA 療法和疫苗的穩定性和效率。這些進步減少了商業化的障礙，並增強了基於 RNA 治療各種疾病的可行性。

COVID-19 大流行凸顯了快速開發疫苗的迫切需求。基於 RNA 的疫苗，例如 Pfizer-BioNTech 和 Moderna 開發的疫苗，在開發和部署方面表現出了前所未有的速度。這一經驗加速了人們對 RNA 技術的興趣和投資，以應對未來的大流行。 FDA 和 EMA 等監管機構已表示願意加快基於 RNA 的療法和疫苗的審查流程，特別是在突發公共衛生事件期間。這種監管支持縮短了上市時間，並鼓勵對 RNA 技術的進一步投資。

基於 RNA 的治療和疫苗市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032）每年將以 65.10% 左右的複合年成長率成長

根據產品類型細分，由於對 RNA 治療藥物的高需求，基於 RNA 的治療藥物預計將在 2023 年顯示最大的市場佔有率。

根據應用細分，由於對治療心血管疾病的 RNA 疫苗的需求不斷成長，心血管疾病領域是 2023 年的領先應用。

根據最終用戶細分，由於對慢性、遺傳和心血管疾病治療的高需求，醫院細分市場將在 2023 年成為領先的最終用戶。

從地區來看，由於傳染病和遺傳疾病的高發生率，北美將成為 2023 年的主要收入來源。

基於 RNA 的治療和疫苗市場細分分析：

全球基於 RNA 的治療和疫苗市場根據產品類型、應用、最終用戶和地區進行細分。

根據產品類型，市場分為兩類：基於 RNA 的治療藥物和基於 RNA 的疫苗。基於 RNA 的疫苗領域主導市場。對精準藥物疫苗和療法的高需求正在推動市場成長。

市場依應用分為七類：腫瘤學、免疫學、眼科、傳染病、心血管疾病、遺傳疾病等。心血管疾病領域佔市場主導地位。遺傳和免疫學相關疾病的增加以及遺傳學的新研究正在推動細分市場的需求。

根據最終用戶，市場分為三類：醫院和診所、研究實驗室等。醫院和診所領域在市場中佔據主導地位，預計在預測期內將保持其高度主導地位。隨著疫苗研究和療法的增加，研究實驗室預計將以最快的速度擴張。

基於 RNA 的治療和疫苗市場 - 地理洞察

在全球範圍內，基於 RNA 的治療和疫苗市場廣泛分佈於北美、拉丁美洲、歐洲、亞太地區、中東和非洲地區。北美主導全球市場。許多基於 RNA 的開創性療法和疫苗都源自該地區的公司，並得到了強大研究機構和創投資金的支持。美國 FDA 在促進基於 RNA 的療法的開發和批准方面的積極立場鼓勵了美國的投資並加速了商業化。

基於 RNA 的治療與疫苗市場-競爭格局：

基於 RNA 的治療藥物和疫苗市場的特點是幾家主要公司之間競爭激烈。市場參與者正在積極推動以 RNA 為基礎的療法，涵蓋多種疾病，包括癌症、遺傳性疾病、傳染病和代謝疾病。正在進行的臨床試驗和臨床前研究旨在將 RNA 技術的治療應用擴展到 COVID-19 大流行之外。學術界、生物技術公司和製藥公司之間的合作正在推動基於 RNA 的療法的創新。這些合作夥伴關係利用 RNA 生物學、藥物傳遞和臨床開發的不同專業知識，加速研究成果向商業產品的轉化。

最近的發展：

2023年8月，CureVac與葛蘭素史克合作開發二價mRNA COVID-19疫苗。

2022年3月，Moderna已開始第二階段HIV疫苗試驗。

目錄

第 1 章：基於 RNA 的治療和疫苗市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 基於 RNA 的治療和疫苗市場片段（按產品類型）
    • 基於 RNA 的治療和疫苗市場片段（按應用）
    • 最終用戶的基於 RNA 的治療和疫苗市場片段
    • 基於 RNA 的治療和疫苗市場片段（按國家/地區）
    • 基於 RNA 的治療和疫苗市場片段（按地區）
  • 競爭洞察

第 3 章：基於 RNA 的治療藥物和疫苗主要市場趨勢

  • 基於 RNA 的治療和疫苗市場促進因素
    • 市場促進因素的影響分析
  • 基於 RNA 的治療和疫苗市場限制
    • 市場限制影響分析
  • 基於 RNA 的治療和疫苗市場機會
  • 基於 RNA 的治療和疫苗市場未來趨勢

第 4 章：基於 RNA 的治療藥物和疫苗產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：基於 RNA 的治療和疫苗市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：基於 RNA 的治療與疫苗市場格局

  • 2024 年基於 RNA 的治療藥物和疫苗市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：基於 RNA 的治療和疫苗市場 - 按產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 基於RNA的治療
    • 基於RNA的疫苗

第 8 章：基於 RNA 的治療和疫苗市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 腫瘤學
    • 免疫學
    • 眼科
    • 傳染病
    • 心血管疾病
    • 遺傳疾病
    • 其他

第 9 章：基於 RNA 的治療和疫苗市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院及診所
    • 研究實驗室
    • 其他

第 10 章：基於 RNA 的治療和疫苗市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美基於 RNA 的治療藥物和疫苗主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲基於 RNA 的治療藥物和疫苗主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區基於 RNA 的治療藥物和疫苗主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（依產品類型）
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲基於 RNA 的治療藥物和疫苗主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按產品類型）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲基於 RNA 的治療藥物和疫苗主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按產品類型）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 基於 RNA 的治療和疫苗產業

  • 競爭儀表板
  • 公司簡介
    • Moderna, Inc.
    • Pfizer-BioNTech
    • CureVac
    • Alnylam Pharmaceuticals
    • Arrowhead Pharmaceuticals
    • Translate Bio
    • BioNTech SE
    • Dicerna Pharmaceuticals
    • Regulus Therapeutics
    • Ionis Pharmaceuticals
    • Sirnaomics
    • Marina Biotech
    • Sarepta Therapeutics
    • Arcturus Therapeutics
    • AstraZeneca
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV3080

REPORT HIGHLIGHT

The RNA-based Therapeutics and Vaccines Market size was valued at USD 2.0 Million in 2023, expanding at a CAGR of 65.10% from 2024 to 2032.

RNA-based therapeutics and vaccines represent a modern approach to medical treatments and disease prevention that utilizes RNA molecules as the primary agents for therapy or immunization. RNA vaccines can be developed and manufactured more rapidly than traditional vaccines, as they do not require the production of the pathogen itself.

RNA-based Therapeutics and Vaccines Market- Market Dynamics

Advancement in RNA delivery technologies and personalized medicines are expected to propel market demand

RNA-based therapeutics, such as mRNA therapy, hold promise for personalized medicine. They can be tailored to target specific genetic mutations or disease mechanisms unique to individual patients. This potential for customization aligns with the growing trend toward precision medicine, where treatments are increasingly tailored to individual genetic profiles and disease characteristics. Thus, increased demand for personalized therapies & medicine is expected to fuel the market growth. Additionally, advances in lipid nanoparticles (LNPs) and other delivery systems have significantly improved the stability and efficiency of RNA therapeutics and vaccines. These advancements reduce barriers to commercialization and enhance the feasibility of RNA-based treatments for various diseases.

The COVID-19 pandemic has underscored the urgent need for rapid vaccine development. RNA-based vaccines, such as those developed by Pfizer-BioNTech and Moderna, demonstrated unprecedented speed in development and deployment. This experience has accelerated interest and investment in RNA technology for future pandemic preparedness. Regulatory agencies, such as the FDA and EMA, have demonstrated willingness to expedite review processes for RNA-based therapies and vaccines, particularly during public health emergencies. This regulatory support reduces time to market and encourages further investment in RNA technology.

RNA-based Therapeutics and Vaccines Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 65.10% over the forecast period (2024-2032)

Based on Product Type segmentation, the RNA-based Therapeutics segment was predicted to show maximum market share in the year 2023, owing to the high need for RNA therapeutics.

Based on Application segmentation, cardiovascular diseases segment was the leading Application in 2023, owing to rising demand for RNA vaccines in treatment of cardiovascular diseases.

Based on End User segmentation, hospitals segment was the leading End User in 2023, owing to high demand for treatment of chronic, genetic, and cardiovascular disorders.

On the basis of region, North America was the leading revenue generator in 2023, owing to high prevalence of infectious & genetic diseases.

RNA-based Therapeutics and Vaccines Market- Segmentation Analysis:

The Global RNA-based Therapeutics and Vaccines Market is segmented on the basis of Product Type, Application, End User, and Region.

The market is divided into two categories based on Product Type: RNA-based Therapeutics and RNA-based Vaccines. The RNA-based Vaccines segment dominates the market. High demand for precision medicinal vaccines & therapies are boosting market growth.

The market is divided into seven categories based on the Application: oncology, immunology, ophthalmology, infectious disease, cardiovascular disease, genetic disease, and others. The cardiovascular disease segment dominates the market. Rising genetic and immunology related diseases and new research in genetics is promoting segment demand.

The market is divided into three categories based on End User: hospitals & clinics, research laboratories, and others. The hospitals & clinics segment dominates the market and is expected to maintain its high dominance during the forecast period. Research laboratories is expected to expand at fastest rate with rise in vaccine research & therapies.

RNA-based Therapeutics and Vaccines Market- Geographical Insights

Worldwide, the RNA-based Therapeutics and Vaccines market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America dominates the global market. Many pioneering RNA-based therapeutics and vaccines originate from companies based in this region, supported by robust research institutions and venture capital funding. The US FDA's proactive stance on facilitating the development and approval of RNA-based therapies has encouraged investment and accelerated commercialization in the United States.

RNA-based Therapeutics and Vaccines Market- Competitive Landscape:

The market for RNA-based therapeutics and vaccines is characterized by intense competition among several key companies. Market players are actively advancing RNA-based therapies across a wide range of diseases, including cancer, genetic disorders, infectious diseases, and metabolic conditions. Ongoing clinical trials and preclinical research aim to expand the therapeutic applications of RNA technologies beyond the COVID-19 pandemic. Collaborations between academia, biotech firms, and pharmaceutical companies are driving innovation in RNA-based therapies. These partnerships leverage diverse expertise in RNA biology, drug delivery, and clinical development to accelerate the translation of research into commercial products.

Recent Developments:

In August 2023, CureVac collaborated with GSK for the development of bivalent mRNA COVID-19 vaccines.

In March 2022, Moderna has started second phase HIV vaccine trials.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RNA-BASED THERAPEUTICS AND VACCINES MARKET KEY PLAYERS

  • Moderna, Inc.
  • Pfizer-BioNTech
  • CureVac
  • Alnylam Pharmaceuticals
  • Arrowhead Pharmaceuticals
  • Translate Bio
  • BioNTech SE
  • Dicerna Pharmaceuticals
  • Regulus Therapeutics
  • Ionis Pharmaceuticals
  • Sirnaomics
  • Marina Biotech
  • Sarepta Therapeutics
  • Arcturus Therapeutics
  • AstraZeneca
  • Others

GLOBAL RNA-BASED THERAPEUTICS AND VACCINES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019-2032

  • RNA-based Therapeutics
  • RNA-based Vaccines

GLOBAL RNA-BASED THERAPEUTICS AND VACCINES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Oncology
  • Immunology
  • Ophthalmology
  • Infectious disease
  • Cardiovascular disease
  • Genetic disease
  • Others

GLOBAL RNA-BASED THERAPEUTICS AND VACCINES MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Hospital & Clinics
  • Research Laboratories
  • Others

GLOBAL RNA-BASED THERAPEUTICS AND VACCINES MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. RNA-based Therapeutics and Vaccines Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. RNA-based Therapeutics and Vaccines Market Snippet by Product Type
    • 2.1.2. RNA-based Therapeutics and Vaccines Market Snippet by Application
    • 2.1.3. RNA-based Therapeutics and Vaccines Market Snippet by End User
    • 2.1.4. RNA-based Therapeutics and Vaccines Market Snippet by Country
    • 2.1.5. RNA-based Therapeutics and Vaccines Market Snippet by Region
  • 2.2. Competitive Insights

3. RNA-based Therapeutics and Vaccines Key Market Trends

  • 3.1. RNA-based Therapeutics and Vaccines Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. RNA-based Therapeutics and Vaccines Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. RNA-based Therapeutics and Vaccines Market Opportunities
  • 3.4. RNA-based Therapeutics and Vaccines Market Future Trends

4. RNA-based Therapeutics and Vaccines Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. RNA-based Therapeutics and Vaccines Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. RNA-based Therapeutics and Vaccines Market Landscape

  • 6.1. RNA-based Therapeutics and Vaccines Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. RNA-based Therapeutics and Vaccines Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. RNA-based Therapeutics
    • 7.1.3. RNA-based Vaccines

8. RNA-based Therapeutics and Vaccines Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Oncology
    • 8.1.3. Immunology
    • 8.1.4. Ophthalmology
    • 8.1.5. Infectious disease
    • 8.1.6. Cardiovascular disease
    • 8.1.7. Genetic disease
    • 8.1.8. Others

9. RNA-based Therapeutics and Vaccines Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospital & Clinics
    • 9.1.3. Research Laboratories
    • 9.1.4. Others

10. RNA-based Therapeutics and Vaccines Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. RNA-based Therapeutics and Vaccines Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. RNA-based Therapeutics and Vaccines Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. RNA-based Therapeutics and Vaccines Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. RNA-based Therapeutics and Vaccines Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. RNA-based Therapeutics and Vaccines Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- RNA-based Therapeutics and Vaccines Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Moderna, Inc.
    • 11.2.2. Pfizer-BioNTech
    • 11.2.3. CureVac
    • 11.2.4. Alnylam Pharmaceuticals
    • 11.2.5. Arrowhead Pharmaceuticals
    • 11.2.6. Translate Bio
    • 11.2.7. BioNTech SE
    • 11.2.8. Dicerna Pharmaceuticals
    • 11.2.9. Regulus Therapeutics
    • 11.2.10. Ionis Pharmaceuticals
    • 11.2.11. Sirnaomics
    • 11.2.12. Marina Biotech
    • 11.2.13. Sarepta Therapeutics
    • 11.2.14. Arcturus Therapeutics
    • 11.2.15. AstraZeneca
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE RNA-based Therapeutics and Vaccines Market: Product Type Snapshot (2024)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global RNA-based Therapeutics and Vaccines Market, by Product Type 2019-2032 (USD Million)
  • TABLE RNA-based Therapeutics and Vaccines Market: Application Snapshot (2024)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global RNA-based Therapeutics and Vaccines Market, by Application 2019-2032 (USD Million)
  • TABLE RNA-based Therapeutics and Vaccines Market: End User Snapshot (2024)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global RNA-based Therapeutics and Vaccines Market, by End User 2019-2032 (USD Million)
  • TABLE RNA-based Therapeutics and Vaccines Market: Regional snapshot (2024)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global RNA-based Therapeutics and Vaccines Market, by Region 2019-2032 (USD Million)
  • TABLE North America RNA-based Therapeutics and Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE North America RNA-based Therapeutics and Vaccines Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America RNA-based Therapeutics and Vaccines Market, by Application, 2019-2032 (USD Million)
  • TABLE North America RNA-based Therapeutics and Vaccines Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe RNA-based Therapeutics and Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe RNA-based Therapeutics and Vaccines Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe RNA-based Therapeutics and Vaccines Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe RNA-based Therapeutics and Vaccines Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific RNA-based Therapeutics and Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific RNA-based Therapeutics and Vaccines Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific RNA-based Therapeutics and Vaccines Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific RNA-based Therapeutics and Vaccines Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America RNA-based Therapeutics and Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America RNA-based Therapeutics and Vaccines Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America RNA-based Therapeutics and Vaccines Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America RNA-based Therapeutics and Vaccines Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa RNA-based Therapeutics and Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa RNA-based Therapeutics and Vaccines Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa RNA-based Therapeutics and Vaccines Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa RNA-based Therapeutics and Vaccines Market, by End User, 2019-2032 (USD Million)

List of Figures

  • FIGURE RNA-based Therapeutics and Vaccines Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2024
  • FIGURE Product Type segment market share analysis, 2024 & 2032
  • FIGURE Product Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2024 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End User segment market share analysis, 2024 & 2032
  • FIGURE End User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2024 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America RNA-based Therapeutics and Vaccines Market share and leading players, 2024
  • FIGURE Europe RNA-based Therapeutics and Vaccines Market share and leading players, 2024
  • FIGURE Asia Pacific RNA-based Therapeutics and Vaccines Market share and leading players, 2024
  • FIGURE Latin America RNA-based Therapeutics and Vaccines Market share and leading players, 2024
  • FIGURE Middle East and Africa RNA-based Therapeutics and Vaccines Market share and leading players, 2024
  • FIGURE North America market share analysis by country, 2024
  • FIGURE U.S. RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe RNA-based Therapeutics and Vaccines Market share analysis by country, 2024
  • FIGURE Germany RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific RNA-based Therapeutics and Vaccines Market share analysis by country, 2024
  • FIGURE India RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philipines RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America RNA-based Therapeutics and Vaccines Market share analysis by country, 2024
  • FIGURE Brazil RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa RNA-based Therapeutics and Vaccines Market share analysis by country, 2024
  • FIGURE Saudi Arabia RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)